SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-035096
Filing Date
2024-04-23
Accepted
2024-04-23 06:06:53
Documents
19
Period of Report
2024-04-23

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0204462-6k_immuron.htm 6-K 13952
2 IMMURON CEO STEVEN LYDEAMORE TO PRESENT AT THE WATCHLIST ea020446201ex99-1_immuron.htm EX-99.1 38200
3 GRAPHIC image_001.jpg GRAPHIC 2291
4 GRAPHIC ex99-1_001.jpg GRAPHIC 695518
5 GRAPHIC ex99-1_002.jpg GRAPHIC 1014083
6 GRAPHIC ex99-1_003.jpg GRAPHIC 355273
7 GRAPHIC ex99-1_004.jpg GRAPHIC 581387
8 GRAPHIC ex99-1_005.jpg GRAPHIC 841512
9 GRAPHIC ex99-1_006.jpg GRAPHIC 829825
10 GRAPHIC ex99-1_007.jpg GRAPHIC 1084558
11 GRAPHIC ex99-1_008.jpg GRAPHIC 893567
12 GRAPHIC ex99-1_009.jpg GRAPHIC 400882
13 GRAPHIC ex99-1_010.jpg GRAPHIC 855618
14 GRAPHIC ex99-1_011.jpg GRAPHIC 761296
15 GRAPHIC ex99-1_012.jpg GRAPHIC 910236
16 GRAPHIC ex99-1_013.jpg GRAPHIC 637377
17 GRAPHIC ex99-1_014.jpg GRAPHIC 730748
18 GRAPHIC ex99-1_015.jpg GRAPHIC 424115
19 GRAPHIC ex99-1_016.jpg GRAPHIC 1293612
  Complete submission text file 0001213900-24-035096.txt   17010734
Mailing Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053
Business Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053 61 03 9824 5254
Immuron Ltd (Filer) CIK: 0001660046 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-38104 | Film No.: 24862608
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)